May 1, 2007 ... ... MD; Mayo Clinic, Rochester, MN; University of California-Davis, Sacramento;
and The .... STAMP V consisted of cyclophosphamide 1.5 g/m<sup>2</sup>/d, carboplatin 200
.... Clifford Hudis, Amgen, Bristol-Myers Squibb Research Funds: Julie R. ...
Roche H, Viens P, Biron P, et al: High-dose chemotherapy for breast ...
Dec 23, 2009 ... ‡Repeated measures analysis of variance (combination vs monotherapy). .....
Clifford, Robert Croos, Jane Da Rosa Davis, Lalitha De Silva, Savitha Eranti, ...
Ali Carre, Julia Cartright, Julie Chalmers, Apa Chisuse, Phil Davison, David ...
boards with AstraZeneca, Bristol-Myers Squibb, Lilly, Janssen Cilag, ...
Nov 15, 2015 ... Gary L. Davis, MD, FAASLD (Scientific Program Committee and ... Grant/
Research Support: AbbVie, Bristol Myers Squibb, Gilead, Janssen, Merck ... Julie
Deal .... Colombo et al, Annu Rev Cell dev Biol 2014, 30:255. ..... Rautou PE,
Bresson J, Sainte-Marie Y, Vion AC, Paradis V, Renard JM, Devue C, et al.
Oct 10, 2007 ... Dr. Davis owns stock in and holds intellectual property rights to Coley
Pharmaceuticals Group, Inc. Dr. Bacon ... He also provides research support to
Roche Laboratories, and Bristol-Myers Squibb. .... Julie A. Lekstrom-Himes, ...... 8
Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, et al.
Apr 14, 2004 ... Motion of plaintiffs Madhavi Parvathaneni, et al., for centralization of the following
actions in the ..... Elizabeth Davis, et al. v. Life Insurance ... Bristol-Myers Squibb
Co., et al., C.A. No. 3:03-1668 ..... Julie K. Pullin v. Wyeth, et al.
Jul 13, 2015 ... Cilag, and Bristol-Myers Squibb and speaker's fees from ... activation in the
ventral striatum (VS) during reward anticipation. ... reduced ethanol sensitivity in
ics mutants was not caused by al- ... Ojelade et al. ...... McGuire SE, Le PT,
Osborn AJ, Matsumoto K, Davis RL (2003) Spatiotemporal rescue of.
Jul 28, 2015 ... The results of association analyses between VS and RSU1 gene are
summarized. ROI ..... Janssen-Cilag, and Bristol-Myers Squibb and speaker's
fees from AstraZeneca, .... McGuire SE,; Le PT,; Osborn AJ,; Matsumoto K,; Davis
RL .... Bierut LJ, et al., Gene, Environment Association Studies Consortium.
Aug 16, 2006 ... ObjectiveTo compare the safety/efficacy of 3-drug vs 4-drug regimens for initial
treatment of HIV-1 infection. ... patients could substitute stavudine (Zerit, Bristol-
Myers Squibb) for zidovudine, .... *Details reported in Gulick et al. ...... Jr, MD (
University of Minnesota); Paula Potter, RN, BSN, Julie Hoffman, RN, ...
Nov 15, 2015 ... Grant/Research Support: AbbVie, Bristol Myers Squibb, Gilead, Idenix. Rennie M.
... Gary L. Davis, MD, FAASLD (Scientific Program Committee and Governing
Board). No conflict of ... Julie Deal. No conflict of .... Chen CJ, et al. JAMA. 2006 ...
0% vs. 5%. Adapted from Sarkar M, Hepatology 2014; 60: 448.
Nov 6, 2015 ... Julie Panzica-Kelly,. † ... Discovery Toxicology, Bristol Myers Squibb, Pennington
, New Jersey 08534, United .... (approximately 10 rats) vs animal requirements for
regulatory .... reviewed in 2014 by Lee et al.28,29 Altogether, zebrafish has ..... B.,
Davis, J., Clee, C., Oliver, K., Clark, R., Riddle, C., Elliot, D.,.